July 22 (Reuters) – Arcus Biosciences Inc: * ARCUS BIOSCIENCES AND SUMMIT THERAPEUTICS ENTER INTO CLINICAL TRIAL COLLABORATION TO EVALUATE CASDATIFAN COMBINED WITH IVONESCIMAB IN KIDNEY CANCER Source
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)